Medicare CED Decisions By Local Contractors Would Be Unworkable, Drug Firms Argue
Executive Summary
In comments to the Centers for Medicare and Medicaid Services, drug manufacturers also say CED should continue to be applied only “rarely” for drugs and biologics and should not apply to off-label uses.